News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
salud mental
54% of Europeans consider their current physical health to be good or very good, as survey reveals public perceptions of health following nearly two years of the Covid 19 pandemic
Coronavirus
“Merck Survey: Europeans' perception of health two years after the start of Covid 19” carried out…
Partners - Merck
neurofix pic
Final stretch in phase IIa of clinical trial for ground-breaking Spanish drug indicated to treat paraplegic pain caused by spinal cord injuries
In three months, biotechnology company Neurofix will have the first results of phase IIa of NFX88…
mapa ability
Ability Pharmaceuticals continues with the clinical development for ABTL0812 as a first line therapy in advanced pancreatic cancer simultaneously in US, Europe, and Israel
ABTL0812 is administered in combination with FOLFIRINOX in a double blind, randomized and placebo…
Partners - Ability Pharmaceuticals
neurofix
Neurofix opens final funding round before availability of phase IIa results for its clinical trial on its ground-breaking drug
Increase in capital is set to 3.5 million euros with a discount of 10% on a valuation of 20…
Laura Soucek
Peptomyc opens a 25 million round of investment and secures 8.6 million euros from its current partners
The spin-off from VHIO (Vall d'Hebron Institute of Oncology) and ICREA – Peptomyc – has developed…
almirall pic
Almirall initiates experimental phase of Lebrikizumab trial in AD patients that have failed or are unsuitable to oral Cyclosporine
The ADvantage study, whose principal investigator and coordinator is Professor Richard Warren of…
Partners - Almirall
imagen diversa
DIVERSA plans to attend SLAS2022 in Boston (February 5-9th, 2022)
DIVERSA is an early-stage biotech and drug delivery company founded in 2022 in Santiago de…
Partners - DIVERSA Technologies
foto
New generation of digitised biosensors for cutting-edge food analytical monitoring
Food & feed
The food industry is no stranger to changes and adapts in order to maintain its competitiveness and…
Partners - Biolan
foto protqsar
A new in silico platform that facilitates the evaluation of mutagenicity with regulatory validity launched
Mutagenicity (capacity to alter cellular genetic material) is one of the most important parameters…
Partners - ProtoQSAR